Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Validation: Trenbolone acetate + trenbolone enanthate is a combination of two anabolic–androgenic steroids (AAS), both derivatives of nandrolone, typically used illicitly for bodybuilding and athletic enhancement. Trenbolone acetate is mainly approved for veterinary use to promote muscle growth in livestock, whereas trenbolone enanthate was never marketed officially. Both act as powerful agonists of the androgen receptor, stimulating protein synthesis, increasing nitrogen retention, and boosting red blood cell production. They result in substantial increases in muscle mass, strength, fat loss, and recovery. This combination does not undergo aromatization to estrogen, thus minimizing estrogenic effects; however, it can have potent progestogenic and weak glucocorticoid effects. Purported benefits include enhanced nutrient partitioning, lean muscle development, and protection against muscle and bone loss, but side effects are significant and frequently systemic. Use in humans remains unapproved, with administration typically via deep intramuscular injection during illicit cycles, in doses typically ranging from 300–600 mg/week of each ester for advanced users.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trenbolone acetate + trenbolone enanthate.